Therapy Access
Access Built Over Years. Delivered Day One.
The Challenge
Evolving payer requirements, limited distribution networks, and administrative complexity can delay therapy, fragment care, and make it harder for patients to stay connected to their health system.
Partner Health Systems
Why Health Systems Partner With Us
Dedicated payer and drug access teams help health systems gain, maintain, and expand access while reducing operational burden through unmatched industry relationships.
Dedicated Expertise
Proven Relationships
Network Scale
Ongoing Support
Our Access Solutions
Every health system's path to access is different. That's why we offer a specialized and strategic approach that helps our partners navigate complexity, unlock new opportunities, and build a stronger foundation for long-term growth.
Payer Access & Contracting
Our team of highly specialized payer access experts with experience across every aspect of health system and pharmacy contracting, from PBM pathways and managed care to direct network agreements.
We support our partners through two distinct pathways:
Bespoke Payer Contracting: No two health systems face the same payer landscape. We take a bespoke approach, designing contracting strategies tailored to each organization's market dynamics, competitive position, and priorities. Our team works closely with each partner to identify the opportunities that will have the greatest impact on patient access, program growth, and long-term performance.
Network-level Contracting via the Shields Health Network. Built on the collective strength of the nation's leading health system specialty pharmacy programs, the Shields Health Network enables us to negotiate directly with payers, PBMs, and self-insured employers on behalf of our health system partners through a single participation agreement. The result is faster speed to access, unmatched scale, simplified contracting, and more opportunities to keep specialty care within the health system.
Payer Readiness & Performance Infrastructure
Both of our payer access pathways are backed by the same robust performance infrastructure. Our experts evaluate each specialty pharmacy program holistically, providing the clinical, operational, and reporting support needed to meet evolving payer requirements. From dual accreditation (URAC and ACHC) and disease-specific clinical programs to outcomes measurement, quality monitoring, and compliance reporting, we help our health system partners sustain access, maintain network participation, and reduce administrative burden.
$23B
of Payer Access Unlocked
90%+
Commercial Payer Access Acheived
1,000+
Contracts Secured
~500
Reports Produced Annually to Maintain Payer Access on Behalf of Our Partners
Drug Access & Trade Relations
As manufacturer requirements evolve, our drug access and trade relations teams help health systems navigate complexity and maintain access to specialty and limited distribution therapies.
We help our partners expand and maintain drug access through:
Manufacturer engagement and relationship management
Strategic drug-specific program and design
Limited distribution drug access strategies
Launch readiness planning
Drug pipeline monitoring
Access expansion initiatives
Enhanced data reporting and ETASU REMS programs
Ongoing trade relations support
The Results
90%+
Limited Distribution Drug Access
<2
Days Average Time to Therapy (PA TAT)
93%
Proportion of Days Covered (PDC)/Adherence rate
Get the Access That Powers Connected Performance
Expand access. Strengthen performance. Keep specialty care where it belongs.